Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
- Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
- The collaborative efforts are focused on advancing small molecule development candidates which Merck KGaA, Darmstadt, Germany, will select for further pre-clinical and clinical development.
- Merck KGaA, Darmstadt, Germany, systematically explores data science and AI approaches to accelerate the discovery and delivery of breakthrough medicines.
- All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group website.